Go Pro
→ Bezos… DOOMED (From Paradigm Press) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
$2.16
-0.5%		$1.44
$0.88
▼
$2.28
$252.11M0.791.62 million shs976,170 shs
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
$13.57
+0.4%		$13.43
$13.02
▼
$15.98
$143.52M0.7726,573 shs58,292 shs
10 Best Stocks to Own - Summer 2026 Cover
10 Best Stocks to Own - Summer 2026

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
-0.46%+4.85%+58.82%+94.59%+98.17%
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
+0.33%+0.48%+1.20%-2.13%-13.18%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
$2.16
-0.5%		$1.44
$0.88
▼
$2.28
$252.11M0.791.62 million shs976,170 shs
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
$13.57
+0.4%		$13.43
$13.02
▼
$15.98
$143.52M0.7726,573 shs58,292 shs
10 Best Stocks to Own - Summer 2026 Cover
10 Best Stocks to Own - Summer 2026

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
-0.46%+4.85%+58.82%+94.59%+98.17%
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
+0.33%+0.48%+1.20%-2.13%-13.18%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
2.50
Moderate Buy$10.00362.96% Upside
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest CRDL, SPE, TRCS, and ACSO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/26/2026
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
B. Riley Financial, Inc. logo
B. Riley Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$11.00
8/17/2026
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$8.00 ➝ $10.00
7/14/2026
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
6/24/2026
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
(Data available from 9/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
N/AN/AN/AN/A$0.15 per shareN/A
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
-$24.20M-$0.25N/AN/AN/AN/A-180.44%-140.28%11/12/2026 (Estimated)
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
N/AN/AN/AN/AN/AN/AN/AN/AN/A

Latest CRDL, SPE, TRCS, and ACSO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q2 2026
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
-$0.09-$0.04+$0.05-$0.04N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
N/AN/AN/AN/AN/A
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
$1.5211.20%N/AN/AN/A

Latest CRDL, SPE, TRCS, and ACSO Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/1/2026
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
monthly$0.10879.65%9/22/20269/22/20269/30/2026
7/1/2026
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
monthly$0.10879.78%8/18/20268/18/20268/31/2026
7/1/2026
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
monthly$0.10879.66%7/21/20267/21/20267/31/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
N/A
5.55
5.55
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
12.49%
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
35.60%

Insider Ownership

CompanyInsider Ownership
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
5.25%
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
1.13%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
20116.18 million110.08 millionNot Optionable
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
N/A10.62 million10.50 millionNot Optionable

Recent News About These Companies

Special Opportunities Fund (NYSE:SPE) Stock Crosses Below 200-Day Moving Average - What's Next?
August 29, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30990053
Special Opportunities Fund (NYSE:SPE) Shares Pass Below 200 Day Moving Average - Here's What Happened
August 21, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/special-opportunities-fund-nysespe-shares-pass-below-200-day-moving-average-heres-what-happened-2026-08-21/
Special Opportunities Fund (NYSE:SPE) Shares Cross Below 200 Day Moving Average - Time to Sell?
August 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/special-opportunities-fund-nysespe-shares-cross-below-200-day-moving-average-time-to-sell-2026-08-13/
Special Opportunities Fund Inc
August 7, 2026  |  money.usnews.comhttps://money.usnews.com/investing/stocks/spe-special-opportunities-fund-inc
Special Opportunities Fund (NYSE:SPE) Stock Price Passes Below Two Hundred Day Moving Average - Should You Sell?
August 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/special-opportunities-fund-nysespe-stock-price-passes-below-two-hundred-day-moving-average-should-you-sell-2026-08-05/
Healthcare Special Opportunities Fund: LDIC Inc. Announces the Termination of the Healthcare Special Opportunities Fund
July 24, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-07/69111182-healthcare-special-opportunities-fund-ldic-inc-announces-the-termination-of-the-healthcare-special-opportunities-fund-296.htm
LDIC Inc. Announces the Termination of the Healthcare Special Opportunities Fund
July 23, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/ldic-inc-announces-termination-healthcare-210100983.html
Special Opportunities Fund Announces Distributions For Third Quarter of 2026
July 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/01/3320811/0/en/special-opportunities-fund-announces-distributions-for-third-quarter-of-2026.html
Healthcare Special Opportunities Fund Announces June 2026 Quarterly Distribution
June 14, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/healthcare-special-opportunities-fund-announces-142900623.html
SPE.PR.C Stock Price
June 7, 2026  |  seekingalpha.comhttps://seekingalpha.com/symbol/SPE.PR.C
Griffin Gaming Partners launches $100m indie games fund
May 8, 2026  |  pocketgamer.bizP
Another $100 million to indie games: new fund led by CEO of Manor Lords publisher and strategy powerhouse Hooded Horse praises "breakout hits with comparatively modest budgets"
May 6, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/technology/articles/another-100-million-indie-games-160000549.html
CEO of Manor Lords publisher and strategy powerhouse Hooded Horse heads $100 million indie fund
May 6, 2026  |  msn.comhttps://www.msn.com/en-us/money/other/ceo-of-manor-lords-publisher-and-strategy-powerhouse-hooded-horse-heads-100-million-indie-fund/ar-AA22xj0S
Griffin Gaming Partners launches $100m indie dev fund, led by Hooded Horse CEO Tim Bender
May 6, 2026  |  gamesindustry.bizG
Griffin Gaming Partners Launches $100 Million Fund for Indie Titles With Hollywood Potential (Exclusive)
May 6, 2026  |  hollywoodreporter.comH
Special Opportunities Fund, Inc. declares $0.1087 dividend
April 14, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4574784-special-opportunities-fund-inc-declares-0_1087-dividend?utm_source=marketbeat.com&utm_medium=referral&feed_item_type=news?source=MarketBeat
Special Opportunities Fund Announces Monthly Distributions For Second Quarter of 2026
April 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/13/3272952/0/en/special-opportunities-fund-announces-monthly-distributions-for-second-quarter-of-2026.html
AMG Yacktman Special Opportunities Fund
April 7, 2026  |  money.usnews.comhttps://money.usnews.com/funds/mutual-funds/foreign-small-mid-value/amg-yacktman-special-opportunities-fund/yaslx
InCred Alternatives closes maiden special opportunities credit fund at Rs 1,500 cr
April 7, 2026  |  moneycontrol.comhttps://www.moneycontrol.com/news/business/incred-alternatives-closes-maiden-special-opportunities-credit-fund-at-rs-1-500-cr-13882656.html
InCred Alternatives closes ₹1,500 crore special opportunities fund; private credit AUM crosses ₹4,000 crore
April 7, 2026  |  cnbctv18.comC
InCred Alternatives closes maiden special opportunities credit fund with ₹1,500 crore corpus
April 6, 2026  |  livemint.comhttps://www.livemint.com/companies/news/incred-alternatives-closes-maiden-special-opportunities-credit-fund-at-rs-1-500-crore-11775478620245.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Data center aisle with server racks, blue lighting, and coolant supply and return pipes with gauges.
3 Stocks That Prove the AI Trade Isn't Over, It Moved
By Bridget Bennett | August 5, 2026
AMD logo centered on a glowing semiconductor chip with illuminated circuitry, symbolizing AI GPUs and surging demand in the semiconductor industry.
AMD’s Post-Earnings Drop May Be the Opportunity Investors Wanted
By Thomas Hughes | August 5, 2026
Nvidia logo illuminated in green on a circuit board background with glowing data connection lines.
NVIDIA's $500 Billion GPU Financing Deal Fuels Path Toward $270
By Thomas Hughes | August 14, 2026
Digital display of multiple financial charts, including line, candlestick, bar, heat map, and scatter plot graphs.
3 Unexpected ETFs Crushing the Market This Summer
By Nathan Reiff | August 16, 2026
AST SpaceMobile promotional graphic featuring the company logo, a satellite, and Earth from orbit.
AST SpaceMobile’s Latest BlueBird Launch Raises the Stakes Ahead of Q2 Earnings
By Jessica Mitacek | August 7, 2026
Cardiol Therapeutics stock logo

Cardiol Therapeutics NASDAQ:CRDL

$2.16 -0.01 (-0.46%)
As of 09/3/2026 04:00 PM Eastern

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.

Special Opportunities Fund stock logo

Special Opportunities Fund NYSE:SPE

$13.57 +0.06 (+0.44%)
As of 09/3/2026 03:59 PM Eastern

Special Opportunities Fund, Inc. is a close-ended balanced fund of funds launched and managed by Bulldog Investors, LLC. It invests in close-ended funds investing in public equity and fixed income markets. The fund employs a combination of value, opportunistic and special situations strategies to make its investments. It benchmarks the performance of its portfolio against the S&P 500 Index. The fund was previously known as Insured Municipal Income Fund, Inc. Special Opportunities Fund, Inc. was formed on February 18, 1993 and is domiciled in the United States.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas